1. Home
  2. ACHR vs IRTC Comparison

ACHR vs IRTC Comparison

Compare ACHR & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer Aviation Inc.

ACHR

Archer Aviation Inc.

HOLD

Current Price

$8.47

Market Cap

5.7B

Sector

Industrials

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$157.33

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHR
IRTC
Founded
2018
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.8B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
ACHR
IRTC
Price
$8.47
$157.33
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$12.14
$213.85
AVG Volume (30 Days)
36.5M
455.8K
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$702,573,000.00
Revenue This Year
N/A
$27.20
Revenue Next Year
N/A
$16.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.45
52 Week Low
$5.48
$86.99
52 Week High
$14.62
$212.00

Technical Indicators

Market Signals
Indicator
ACHR
IRTC
Relative Strength Index (RSI) 51.80 30.20
Support Level $8.42 $173.46
Resistance Level $9.24 $190.00
Average True Range (ATR) 0.44 6.90
MACD 0.11 -1.70
Stochastic Oscillator 58.97 10.18

Price Performance

Historical Comparison
ACHR
IRTC

About ACHR Archer Aviation Inc.

Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: